Specifically, BRCA1 germline mutations predispose to the occurrence of triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer (BC) that is negative for the expression of the hormone receptors (HR), ERα and PR, and HER2 [2,3]. The gene discussed is ERBB2; the disease is breast cancer.